Viewing StudyNCT05218603



Ignite Creation Date: 2024-05-06 @ 5:09 PM
Last Modification Date: 2024-10-26 @ 2:23 PM
Study NCT ID: NCT05218603
Status: RECRUITING
Last Update Posted: 2022-09-16
First Post: 2022-01-17

Brief Title: Evaluation of Maintenance With Bortezomib Plus Daratumumab V-Dara After Induction With Bortezomib Melphalan Prednisone Plus Daratumumab VMP-Dara in Newly Diagnosed Multiple Myeloma MM Patients Non-eligible for autoSCT
Sponsor: PETHEMA Foundation
Organization: PETHEMA Foundation

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Non-eligible for Autologous Stem Cell Transplantation ASCT
Keywords:
Name View
Prospective View
Observational study View
Multiple Myeloma View